Prelude Capital Management’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
Other funds holding NUS
VCM
PGCM
VPM
Prelude Capital Management's NUS Position: Q1 2026 in Review
Prelude Capital Management reduced its Nu Skin (NUS) stake by 30% in Q1 2026, selling an estimated $47.7K and leaving 12,313 shares worth $89.6K. The position accounts for 0.01% of the portfolio, ranked #1068.
Prelude Capital Management first reported a position in NUS in Q2 2013 and has held it in 27 quarters since. The position peaked at $326K in Q1 2024. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.
- Prelude Capital Management held 12,313 shares of Nu Skin worth $89.6K as of Q1 2026.
- Prelude Capital Management sold 5,264 Nu Skin shares in Q1 2026, an estimated $47.7K.
- Nu Skin made up 0.01% of Prelude Capital Management's portfolio in Q1 2026, its #1068 holding.
- Prelude Capital Management first reported a position in Nu Skin in Q2 2013 and has held it in 27 quarters since.
- Prelude Capital Management's Nu Skin position peaked at $326K in Q1 2024.
- 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.
Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.